On Tuesday, December 15, from 11 am to noon EST, The American Journal of Managed Care will host a tweetchat with Leah Binder, MA, MGA, president and CEO of The Leapfrog Group, about hospital quality ratings, patient safety, and healthcare outcomes.
PLAINSBORO, N.J.— In the most recent Hospital Safety Score report, The Leapfrog Group found a number of positive trends for certain hospital-acquired conditions and safety measures, but noted that areas for improvement remain.
On Tuesday, December 15, from 11 am to noon EST, The American Journal of Managed Care (AJMC) will host a tweetchat with Leah Binder, MA, MGA, president and CEO of The Leapfrog Group, about hospital quality ratings, patient safety, and healthcare outcomes.
Binder, who was the keynote speaker at AJMC’s ACO and Emerging Healthcare Delivery Coalition fall live meeting in October, will answer questions from participants and discuss topics that include the relevancy of individual hospital quality ratings, how the use of health technology has affected patient safety, and how consumers view quality ratings.
“Although progress has been made, we still need more transparency and accountability in our health care system,” said Binder. “I’m honored to partner with AJMC to have an open conversation with hospitals and purchasers on ways to improve quality, patient safety and transparency for consumers.”
AJMC and The Leapfrog Group encourage Twitter users to submit questions and participate in the chat on Tuesday, December 15, by using #AJMCchat. And don’t forget to follow @AJMC_Journal, @LeahBinder, and @LeapfrogGroup.
In March 2015, Binder wrote a commentary for AJMC’s sister publication, The American Journal of Accountable Care, highlighting the expanding surge of consumerism in healthcare.
About the Journals
The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
About The Leapfrog Group
Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps forward in the quality and safety of American health care. The flagship Leapfrog Hospital Survey collects and transparently reports hospital performance, empowering purchasers to find the highest-value care and giving consumers the lifesaving information they need to make informed decisions. Hospital Safety Score, Leapfrog’s other main initiative, assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents, and infections.
Nicole Beagin (609) 716-7777 x 131
CONTACT:
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
Why Right Heart Catheterization Confirming PAH Diagnosis May Be Underperformed
November 20th 2024Professional guidelines say that when pulmonary arterial hypertension (PAH) is diagnosed, right heart catheterization should be performed, but a quarter of the time, it isn’t—so investigators set out to discover why.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
New PsA Data Highlight Long-Term Benefits of Bimekizumab
November 19th 2024A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active psoriatic arthritis (PsA).
Read More